Cargando…

Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Shah, Melisa M., Joyce, Brendan, Plumb, Ian D., Sahakian, Sam, Feldstein, Leora R., Barkley, Eric, Paccione, Mason, Deckert, Joseph, Sandmann, Danessa, Gerhart, Jacqueline L., Hagen, Melissa Briggs
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721144/ https://www.ncbi.nlm.nih.gov/pubmed/36454693 http://dx.doi.org/10.15585/mmwr.mm7148e2

Ejemplares similares

Paxlovid associated with decreased hospitalization rate among adults with COVID-19 — United States, April–September 2022
por: Shah, Melisa M., et al.
Publicado: (2023)

Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022
por: Plumb, Ian D., et al.
Publicado: (2022)

Nirmatrelvir/ritonavir (Paxlovid®): French pharmacovigilance survey 2022
por: Bihan, Kevin, et al.
Publicado: (2023)

The Path to Paxlovid
por: Halford, Bethany
Publicado: (2022)

COVID-19 rebound after Paxlovid and Molnupiravir during January-June 2022
por: Wang, Lindsey, et al.
Publicado: (2022)

Prevalence of Mpox (Monkeypox) in patients undergoing STI screening in northern California, April-September 2022
por: Contag, Caitlin A., et al.
Publicado: (2023)

The future of Paxlovid for COVID-19
por: Burki, Talha
Publicado: (2022)

Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023)

Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient
por: Shah, Aaisha, et al.
Publicado: (2022)

49-April 2022
Publicado: (2022)

In the literature: April 2022
por: Ciardiello, D., et al.
Publicado: (2022)

1937. Use of Paxlovid for Treatment of Acute COVID-19 and Occurrence of Post-COVID Conditions among Children and Adults at High-Risk for Severe COVID-19, April 1 - December 31, 2022
por: Dalton, Alexandra F, et al.
Publicado: (2023)

Population-Level Immunity for Transient Suppression of COVID-19 Waves in Japan from April 2021 to September 2022
por: Kodera, Sachiko, et al.
Publicado: (2023)

In the Limelight: September 2022
por: Nath, Karl A.
Publicado: (2022)

Paxlovid™ jetzt direkt an Patienten abgeben
por: Zimmermann, Gerd W.
Publicado: (2022)

Paxlovid-Induced Symptomatic Bradycardia and Syncope
por: Ganipisetti, Venu M, et al.
Publicado: (2023)

CARDIOGENIC SHOCK DUE TO PAXLOVID INTERACTION
por: Enstrom, Cate, et al.
Publicado: (2023)

Serotonin Syndrome Precipitated by Paxlovid Initiation
por: Nasser, Nicholas G, et al.
Publicado: (2023)

Patterns of social mixing in England changed in line with restrictions during the COVID-19 pandemic (September 2020 to April 2022)
por: Smith, Louise E., et al.
Publicado: (2022)

INTERPRETIVE SUMMARIES, APRIL 2022
Publicado: (2022)

Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status — United States, April 2021–September 2022
por: Jones, Jefferson M., et al.
Publicado: (2023)

Introduction to the September 2022 Issue
por: Hodges, Charles B.
Publicado: (2022)

Editors’ Message September 2022
por: Michos, Erin D., et al.
Publicado: (2022)

Risks of paxlovid in a heart transplant recipient
por: Stawiarski, Kristin, et al.
Publicado: (2023)

Paxlovid: Mechanism of Action, Synthesis, and In Silico Study
por: Marzi, Mahrokh, et al.
Publicado: (2022)

Carfilzomib Induced Microangiopathy due to Accumulation With Paxlovid
por: Philipponnet, Carole, et al.
Publicado: (2022)

A Rare Case of Paxlovid-Induced Pancreatitis
por: Zaidi, Syed Muhammad Hussain, et al.
Publicado: (2023)

Epilepsia Open—September 2022—Announcements
Publicado: (2022)

Answer to September 2022 Photo Quiz
por: Dupont, D., et al.
Publicado: (2022)

Computational prediction of interactions between Paxlovid and prescription drugs
por: Kim, Yeji, et al.
Publicado: (2023)

Compulsory psychiatric admissions in the canton of Basel-Stadt between September 2013 and April 2022: Analysis of the cantonal database of the Health Department of Basel-Stadt
por: Schneider, Michael, et al.
Publicado: (2022)

Human vaccines & immunotherapeutics: news April 2022
por: Ellis, Ron, et al.
Publicado: (2022)

Victor F. Weisskopf: 19 September 1908 - 21 April 2002
por: Jacob, Maurice René Michel
Publicado: (2002)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Efficacy and safety of Paxlovid for COVID-19:a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023)

Paxlovid(TM) Information From FDA and Guidance for AES Members
por: Cokley, Jon A., et al.
Publicado: (2022)

Projected COVID-19 Mortality Reduction From Paxlovid Rollout
por: Khunte, Mihir, et al.
Publicado: (2023)

Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
por: Sánchez Fabra, David, et al.
Publicado: (2023)

Paxlovid for hospitalized COVID-19 patients with chronic kidney disease
por: Cai, Hong, et al.
Publicado: (2023)

Activation of PXR causes drug interactions with Paxlovid in transgenic mice
por: Lei, Saifei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c7jmbvlap9bnsb1s82e7ugbb54